SCOTT SALOMONE: Open Payments
NPI 1386178481 · MURRAY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,373 in 76 payments from 12 companies in 2025. Trend: 2023 $1,161 · 2024 $1,088 · 2025 $1,373
Food & beverage: $1,271Education: $101
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $305 |
| Teva Pharmaceuticals USA, Inc. | 14 | $300 |
| Neurocrine BioSciences, Inc. | 9 | $204 |
| E.R. Squibb & Sons, L.L.C. | 19 | $175 |
| Janssen Pharmaceuticals, Inc | 5 | $117 |
| Lundbeck LLC | 4 | $80 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
Products named: VRAYLAR, INGREZZA, AUSTEDO XR, COBENFY, REXULTI, INVEGA SUSTENNA, SPRAVATO, Auvelity.
Industry payments across UT — which companies pay providers there.
